While YTHDF2 knockdown has been shown to inhibit HCC cell proliferation [50], other studies have highlighted its tumor-suppressive role by targeting genes such as EGFR, IL11, and SRPINE2 [51]. This evidence concerns the gene EGFR and neoplasm.